BioSpace News Archive

Aridis Pharmaceuticals, Inc. announced that it has entered into a definitive agreement for the issuance and sale of an aggregate of 6,000,000 shares of the Company’s common stock at a purchase price of $0.38 per share in a registered direct offering.

The American Urological Association is pleased to announce the ten companies chosen through a rigorous and highly competitive selection process for the inaugural Innovation Nexus Showcase.

Horizon Therapeutics plc (Nasdaq: HZNP) today announced the presentation of new MRI imaging data from the Phase 3 clinical trial showing UPLIZNA reduced the formation of subclinical (asymptomatic) optic nerve lesions in people with NMOSD.

SkinCure Oncology today announced the successful Image-Guided SRT treatment of the 50,000th patient in the United States.

The U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency.

Pardes Biosciences, Inc. reported financial results for the fourth quarter and full year ended December 31, 2022 and provided a business update.

Design Therapeutics, Inc., a clinical-stage biotechnology company developing treatments for serious degenerative genetic diseases, highlighted recent progress and anticipated upcoming milestones across its clinical and research-stage pipeline of novel GeneTAC™ small molecules and reported fourth quarter and full year 2022 financial results.

Arbutus Biopharma Corporation announced that preclinical data for AB-343, our novel oral SARS-CoV-2 Mpro inhibitor, has been presented in poster format at the 36th International Conference on Antiviral Research, in Lyon, France.

Yield10 Bioscience, Inc., an agricultural bioscience company, reported financial results for the fourth quarter and full year ended December 31, 2022.

ENDRA Life Sciences Inc., a pioneer of Thermo Acoustic Enhanced UltraSound, reported financial results for the three months and year ended December 31, 2022, and provided a business update.